[go: up one dir, main page]

ES543236A0 - Un procedimiento para preparar un derivado de dihidropirida-zinona - Google Patents

Un procedimiento para preparar un derivado de dihidropirida-zinona

Info

Publication number
ES543236A0
ES543236A0 ES543236A ES543236A ES543236A0 ES 543236 A0 ES543236 A0 ES 543236A0 ES 543236 A ES543236 A ES 543236A ES 543236 A ES543236 A ES 543236A ES 543236 A0 ES543236 A0 ES 543236A0
Authority
ES
Spain
Prior art keywords
zinona
dihydropiride
derivative
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES543236A
Other languages
English (en)
Other versions
ES8700242A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES8700242A1 publication Critical patent/ES8700242A1/es
Publication of ES543236A0 publication Critical patent/ES543236A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES543236A 1984-05-19 1985-05-17 Un procedimiento para preparar un derivado de dihidropirida-zinona Expired ES8700242A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848412864A GB8412864D0 (en) 1984-05-19 1984-05-19 Chemical compounds

Publications (2)

Publication Number Publication Date
ES8700242A1 ES8700242A1 (es) 1986-09-16
ES543236A0 true ES543236A0 (es) 1986-09-16

Family

ID=10561228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543236A Expired ES8700242A1 (es) 1984-05-19 1985-05-17 Un procedimiento para preparar un derivado de dihidropirida-zinona

Country Status (11)

Country Link
US (1) US4652563A (es)
EP (1) EP0168921A3 (es)
JP (1) JPS60255776A (es)
AU (1) AU4260585A (es)
DK (1) DK216285A (es)
ES (1) ES8700242A1 (es)
FI (1) FI851979A0 (es)
GB (1) GB8412864D0 (es)
GR (1) GR851200B (es)
PT (1) PT80488B (es)
ZA (1) ZA853739B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
US4931430A (en) * 1987-12-14 1990-06-05 E. R. Squibb & Sons, Inc. Method for preventing or treating anxiety employing an ACE inhibitor
US5096904A (en) * 1989-09-01 1992-03-17 Glaxo Inc. Pyridazinones having cardiotonic and beta blocking activities
WO1993010097A1 (en) * 1991-11-15 1993-05-27 Fujisawa Pharmaceutical Co., Ltd. Nitro compounds having vasodilator activity
US5935945A (en) * 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5969017A (en) * 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US20030069318A1 (en) * 2001-08-21 2003-04-10 Wenbin Dang Salts of analgesic substances in oil, and methods of making and using the same
DK2279729T3 (da) * 2003-07-17 2016-11-28 Banner Life Sciences Llc Præparater med kontrolleret frigivelse
CN1300079C (zh) * 2004-12-03 2007-02-14 南京大学 合成4－[2－(环丙基甲氧基)乙基]苯酚的新工艺
FR3036396B1 (fr) * 2015-05-22 2020-02-28 Axon Cable Composition de verre pour le scellement de connecteur micro-d

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3746712A (en) * 1971-06-08 1973-07-17 A Ross 6-(substituted-phenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinones
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
JPS58146570A (ja) * 1982-02-25 1983-09-01 Teikoku Hormone Mfg Co Ltd ピリダジノン誘導体

Also Published As

Publication number Publication date
EP0168921A2 (en) 1986-01-22
JPS60255776A (ja) 1985-12-17
FI851979A0 (fi) 1985-05-17
AU4260585A (en) 1985-11-21
GB8412864D0 (en) 1984-06-27
PT80488B (en) 1987-04-21
DK216285A (da) 1985-11-20
GR851200B (es) 1985-11-25
ES8700242A1 (es) 1986-09-16
DK216285D0 (da) 1985-05-15
PT80488A (en) 1985-06-01
US4652563A (en) 1987-03-24
ZA853739B (en) 1986-12-30
EP0168921A3 (en) 1986-11-05

Similar Documents

Publication Publication Date Title
ES552468A0 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
ES542051A0 (es) Un procedimiento para preparar derivados de benzoilurea
ES543047A0 (es) Un procedimiento para preparar un derivado de pirimidina
ES539563A0 (es) Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol
ES545771A0 (es) Un procedimiento para preparar derivados de quiniona.
ES545347A0 (es) Un procedimiento para preparar derivados de pirimidina
ES556026A0 (es) Un procedimiento para preparar derivados de tienopiridona
ES548409A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES543932A0 (es) Un metodo para preparar un derivado de cefem
ES552537A0 (es) Un procedimiento para preparar un derivado de semicarbazida
ES547419A0 (es) Un procedimiento para preparar derivados de pirimidina
ES544090A0 (es) Un procedimiento para preparar un derivado de ester de des- glucoteicoplanina
ES557395A0 (es) Un procedimiento para preparar derivados arilicos de dienamidas
ES543236A0 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
ES545894A0 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES545111A0 (es) Un procedimiento para preparar un derivado de fluoralilamina
ES541948A0 (es) Un metodo para preparar un derivado de 9-bencilpurina
ES557566A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona
ES546914A0 (es) Procedimiento para preparar un derivado de (imina ciclica)- difenil-eter
ES547458A0 (es) Un procedimiento para preparar derivados de piridiloxi
ES546574A0 (es) Procedimiento para preparar derivados de saframicina a
ES548413A0 (es) Un procedimiento para preparar un derivado triciclico de pi-ridazinona
ES557157A0 (es) Un procedimiento para preparar derivados de alcanoles heteropoliciclicos
ES541321A0 (es) Procedimiento para preparar un derivado de fenotiazina
ES537098A0 (es) Un procedimiento para preparar derivados de tiadiazina